Sort   by:  
 Page size 
UnknownGemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531.
Not available
S-EPMC4162498 | biostudies-literature
UnknownMicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia.
Not available
S-EPMC5721230 | biostudies-literature
UnknownGemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531.
Not available
S-EPMC8478392 | biostudies-literature
UnknownPrevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.
Not available
S-EPMC2918327 | biostudies-literature
UnknownWT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group.
Not available
S-EPMC3056655 | biostudies-literature
UnknownCytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology Group.
Not available
S-EPMC8919970 | biostudies-literature
UnknownGenomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children's Oncology Group report.
Not available
S-EPMC5465840 | biostudies-literature
UnknownRationale and design of the Children's Oncology Group study AAML1831 integrated cardiac substudies in pediatric acute myeloid leukemia therapy.
Not available
S-EPMC10722184 | biostudies-literature
UnknownOptimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia.
Not available
S-EPMC11225675 | biostudies-literature
UnknownMeasurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Munster Study Group.
Not available
S-EPMC10414713 | biostudies-literature
Sort   by:  
 Page size